<code id='0F9091EA66'></code><style id='0F9091EA66'></style>
    • <acronym id='0F9091EA66'></acronym>
      <center id='0F9091EA66'><center id='0F9091EA66'><tfoot id='0F9091EA66'></tfoot></center><abbr id='0F9091EA66'><dir id='0F9091EA66'><tfoot id='0F9091EA66'></tfoot><noframes id='0F9091EA66'>

    • <optgroup id='0F9091EA66'><strike id='0F9091EA66'><sup id='0F9091EA66'></sup></strike><code id='0F9091EA66'></code></optgroup>
        1. <b id='0F9091EA66'><label id='0F9091EA66'><select id='0F9091EA66'><dt id='0F9091EA66'><span id='0F9091EA66'></span></dt></select></label></b><u id='0F9091EA66'></u>
          <i id='0F9091EA66'><strike id='0F9091EA66'><tt id='0F9091EA66'><pre id='0F9091EA66'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:5715
          The US Supreme Court silhouetted -- Abortion coverage from STAT
          STEFANI REYNOLDS/AFP via Getty Images

          WASHINGTON — The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

          The justices seemed by turns relucant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers.

          advertisement

          The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. The Sacklers would contribute up to $6 billion and give up ownership of the company, but retain billions more. The company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          Grail is spending more than ever lobbying Congress
          Grail is spending more than ever lobbying Congress

          GrailGrailspentmorethan$1millionlastquarterlobbyingCongress,underscoringtheurgencyofthecompany’sbidt

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Sage hopes for a blockbuster in antidepressant now before FDA

          AdobeCherylMeierhadwatchedclinicaltrialenrollmentannouncementsforyears—butalwaysforhersons’type1diab